Skip to content
Study details
Enrolling now

45th Multicenter Airway Research Collaboration

Massachusetts General Hospital
NCT IDNCT07166939ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

1,860

Study length

about 9 months

Ages

18–54

Locations

1 site in OH

What this study is about

This trial is testing a treatment called Airsupra for people with asthma. The goal is to see if starting Airsupra in the emergency department helps prevent asthma attacks from happening again after 3 months, along with other related outcomes.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Airsupra

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Body systems

Respiratory